IthaID: 3549



Names and Sequences

Functionality: Disease modifying mutation Pathogenicity: N/A
Common Name: 27bp-VNTR HGVS Name: NG_011992.1:g.11166_11192[4]

Also known as: eNOS4a/b

Comments: 27-bp repeat VNTR polymorphism, aka eNOS4a/b, in intron 4 of NOS3 gene. The wild type allele 'b' comprises five copies of 27 bp repeats. The mutant allele 'a' comprises four copies of 27 bp repeats. The eNOS4a allele associated with a higher number of neutrophils in patients with sickle cell anaemia attending the Hospital de Dona Estefânia, Lisbon (n=26). Nitric oxide exerts regulatory effects on neutrophil, with low concentrations being stimulatory [PMID: 27802215]. It associated with red blood cell disaggregation threshold (i.e.: RBC aggregates strength), which affects risk of acute chest syndrome, in individuals from Guadeloupe with sickle cell disease (SCD) (n=241) [PMID: 26142331]. It associated with risk of vaso-occlusive crisis and pulmonary hypertension in Egyptian SCD patients (100 cases; 80 control) [PMID: 26903375]. VNTR 4b_allele showed a negative association with silent cerebral infarct events in pediatric patients with sickle cell anemia of sub-Saharan African ancestry in Portugal [PMID: 32434137].

We follow the HGVS sequence variant nomenclature and IUPAC standards.

External Links

No available links

Location

Chromosome: 7
Locus: NG_011992.1
Locus Location: 11166
Size: 27 bp
Located at: NOS3

Other details

Type of Mutation: Repeat
Ethnic Origin: Portuguese, Guadeloupean, Egyptian, sub-Saharan African
Molecular mechanism: N/A
Inheritance: Quantitative trait
DNA Sequence Determined: Yes

In silico pathogenicity prediction

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage. Otherwise, use this external link.

Publications / Origin

  1. Ferdinand S, Connes P, Brudey L, Cita KC, Tressières B, Lemonne N, Hardy-Dessources MD, Lamarre Y, Waltz X, Etienne-Julan M, Romana M, Impact of eNOS polymorphisms on red blood cell aggregation in sickle cell disease., Blood Cells Mol. Dis. , 55(2), 151-3, 2015 PubMed
  2. Yousry SM, Ellithy HN, Shahin GH, Endothelial nitric oxide synthase gene polymorphisms and the risk of vasculopathy in sickle cell disease., Hematology , 21(6), 359-67, 2016 PubMed
  3. Aguiar L, Matos A, Gil Â, Afonso C, Braga L, João L, Kjollerstrom P, Faustino P, Bicho M, Inácio Â, Sickle cell anemia - Nitric oxide related genetic modifiers of hematological and biochemical parameters., Clin. Hemorheol. Microcirc. , 2016 PubMed
  4. Silva M, Vargas S, Coelho A, Ferreira E, Mendonça J, Vieira L, Maia R, Dias A, Ferreira T, Morais A, Soares IM, Lavinha J, Silva R, Kjöllerström P, Faustino P, Biomarkers and genetic modulators of cerebral vasculopathy in sub-Saharan ancestry children with sickle cell anemia., Blood Cells Mol Dis, 83(0), 102436, 2020 PubMed
Created on 2019-12-18 17:12:46, Last reviewed on 2022-03-24 11:44:37 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.